| |
|
|
|
Soleno Therapeutics Inc.  
|
|
1.48 -0.09 (-0.06%) |
10-16 16:00 |
|
Open: |
1.55 |
Pre close: |
1.57 |
Target:
|
2.00
|
|
High: |
1.57 |
Low: |
1.45 |
Resistance:
|
1.71
1.90
|
|
Volume: |
26,631 |
Market Cap: |
47M |
Support:
|
1.41
1.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.58
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
1.67 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
2.21 |
Stochastic Oscillator |
%K(14,3):
|
27.43 |
|
MA(250): |
2.02 |
%D(3): |
35.65 |
|
Average Volume(K) |
3-Month: |
3639
|
52-Week |
High:
|
5.07 |
|
10-Days: |
1795 |
Low: |
1.11 |
|
RSI |
RSI(14):
|
36.72 |
Change(%): |
-26.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.726 |
Return on Equity (ttm) |
-127.7 |
Shares Out. (M) |
31.79 |
|
EPS Est. Current Year |
-1.350 |
Return on Assets (ttm) |
-32.3 |
Shares Float (M) |
8.17 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.50 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
61.27 |
|
Forward EPS |
-0.791 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
413 |
|
Book Value (p.s.) |
0.440 |
EBITDA (p.s.) |
-0.486 |
P/E |
-2.04 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.36 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.99 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.85 |
P/CF |
-3.36 |
|
|
|
|
|
|
